Jump to content

Scavenger receptor (immunology): Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Line 45: Line 45:
== External links ==
== External links ==
* {{MeshName|Scavenger+receptors}}
* {{MeshName|Scavenger+receptors}}
* [http://membranome.org/families.php?superfamily=4 Human scavenger-like receptors] in Membranome database


{{Pattern recognition receptors}}
{{Pattern recognition receptors}}

Revision as of 02:00, 7 May 2016

Scavenger receptors are a group of receptors that recognize modified low-density lipoprotein[1] (LDL) by oxidation or acetylation. This naming is based on a function of cleaning (scavenging): Scavenger receptors widely recognize and take up macromolecules that have a negative charge, like modified LDL.

Function

It is thought that scavenger receptors participate in the removal of many foreign substances and waste materials in the living body by extensive ligand specificity and a variety of receptor molecules.

In atherosclerotic lesions, macrophages that express scavenger receptors on their plasma membrane take up the oxidized LDL deposited in the blood vessel wall aggressively, and develop into foam cells. Likewise they secrete various inflammatory cytokines and accelerate the development of atherosclerosis.

Types

Scavenger receptors are categorized into classes A, B, and C according to their structural characteristics.

Class A

Scavenger receptors type 1 (SR-A1) and 2 (SR-A2) are trimers with a molecular weight of about 220-250 kDa (the molecular weight of monomeric protein is about 80 kDa). They preferentially bind modified LDL, either acylated (acLDL) or oxidized (oxLDL). They have a collagen-like domain, which is essential for ligand binding.

Members include:

  • SCARA1 or MSR1: SR-A1 scavenger receptors have a cysteine-rich domain, which can be found in a series of cell surface receptors and soluble proteins, but SR-A2 do not.
  • SCARA2 or MARCO: Another scavenger receptor class A, MARCO, has collagen-like and cysteine-rich domains.
  • SCARA3
  • SCARA4 or COLEC12
  • SCARA5

Class B

CD36 and scavenger receptor class BI (SR-BI) are identified as oxidized LDL receptors and classified into class B. Both proteins have two transmembrane domains, and they are concentrated in a specific plasma membrane microdomain, the caveolae.

Members include:

  • SCARB1. SR-BI can interact not only with oxidized LDL but also with normal LDL and high-density lipoproteins (HDL). Recent studies have indicated that SR-BI is likely to be the major receptor involved in HDL metabolism in mice and humans.[3][4]
  • SCARB2
  • SCARB3 or CD36. CD36 has been thought to be implicated in cell adhesion, in the phagocytosis of apoptotic cells, and in the metabolism of long-chain fatty acids. In experimental mice models of atherosclerosis in which the gene for CD36 has been deleted, the mice have a greatly reduced number of atherosclerotic lesions.[5]

Other

Some receptors that can bind to oxidized LDL have been discovered.

References

  1. ^ Prabhudas M, Bowdish D, Drickamer K, Febbraio M, Herz J, Kobzik L, Krieger M, Loike J, Means TK, Moestrup SK, Post S, Sawamura T, Silverstein S, Wang XY, El Khoury J (2014). "Standardizing scavenger receptor nomenclature". J. Immunol. 192 (5): 1997–2006. doi:10.4049/jimmunol.1490003. PMID 24563502.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H (1990). "Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions". Proc. Natl. Acad. Sci. U.S.A. 87 (23): 9133–7. doi:10.1073/pnas.87.23.9133. PMC 55118. PMID 2251254.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M (1997). "A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism". Proc. Natl. Acad. Sci. U.S.A. 94 (23): 12610–5. doi:10.1073/pnas.94.23.12610. PMC 25055. PMID 9356497.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Khovidhunkit W (2011). "A genetic variant of the scavenger receptor BI in humans". N. Engl. J. Med. 364 (14): 1375–6, author reply 1376. doi:10.1056/NEJMc1101847#SA1. PMID 21470028.
  5. ^ Kuchibhotla S, Vanegas D, Kennedy DJ, Guy E, Nimako G, Morton RE, Febbraio M (2008). "Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II". Cardiovasc. Res. 78 (1): 185–96. doi:10.1093/cvr/cvm093. PMC 2810680. PMID 18065445.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G (2006). "Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders". Cardiovasc. Res. 69 (1): 36–45. doi:10.1016/j.cardiores.2005.09.006. PMID 16324688.{{cite journal}}: CS1 maint: multiple names: authors list (link)